TEVA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.55%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $16,398,934.87

Teva Pharmaceutical Industries Insider Trading History Chart

Teva Pharmaceutical Industries Share Price & Price History

^$16.38

▼ -0.085 (-0.52%)

As of 03/14/2025 04:59 PM ET

Days: 30 | 90 | 365

Teva Pharmaceutical Industries Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/20/2024	Roberto Mignone	Director	Sell	286,000	$22.01	$6,294,860.00	695,000
11/20/2024	Christine Fox	EVP	Sell	19,388	$16.87	$327,075.56	44,104
8/1/2024	Eric A Hughes	Insider	Sell	24,537	$17.25	$423,263.25	45,060
6/18/2024	Roberto Mignone	Director	Sell	519,000	$17.03	$8,838,570.00	981,000
5/15/2024	Amir Weiss	CAO	Sell	15,500	$16.80	$260,400.00	17,814
5/13/2024	Vikki L. Conway	Insider	Sell	15,219	$16.74	$254,766.06
3/5/2024	Mark Sabag	EVP	Sell	100,000	$13.52	$1,352,000.00	382,590
2/28/2024	Eric Drape	VP	Sell	9,815	$13.12	$128,772.80	9,701
2/28/2024	Vikki L. Conway	Insider	Sell	1,366	$13.12	$17,921.92	2,928
2/16/2024	Eric Drape	VP	Sell	173,261	$13.05	$2,261,056.05	1
2/15/2024	Richard D. Francis	CEO	Sell	74,530	$13.15	$980,069.50	87,125
2/1/2024	Amir Weiss	CAO	Sell	31,766	$12.37	$392,945.42	10,676
8/7/2023	Eliyahu Sharon Kalif	CFO	Sell	35,125	$9.73	$341,766.25	99,162
8/4/2023	Amir Weiss	CAO	Sell	1,981	$9.92	$19,651.52	42,442
8/1/2023	Eric A. Hughes	insider	Sell	52,742	$8.30	$437,758.60
3/6/2023	David Matthew Stark	VP	Sell	16,491	$9.93	$163,755.63	52,449
3/6/2023	Sven Dethlefs	EVP	Sell	19,355	$9.93	$192,195.15	223,447
2/28/2023	David Matthew Stark	VP	Sell	63,383	$9.89	$626,857.87	2,974
2/28/2023	Sven Dethlefs	EVP	Sell	59,655	$9.89	$589,987.95	165,381
8/22/2022	Eliyahu Sharon Kalif	CFO	Sell	55,500	$10.07	$558,885.00	9,376
7/28/2022	David Matthew Stark	VP	Sell	58,163	$9.04	$525,793.52	2,974
5/17/2022	Hafrun Fridriksdottir	VP	Sell	130,000	$8.22	$1,068,600.00	1,387

See Full Table

SEC Filings (Institutional Ownership Changes) for Teva Pharmaceutical Industries (NYSE:TEVA)

54.05% of Teva Pharmaceutical Industries stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Teva Pharmaceutical Industries Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/14/2025	Hara Capital LLC	30,380	$0.67M	0.4%	-7.3%	0.003%
3/12/2025	Centaurus Financial Inc.	35,279	$0.78M	0.0%	+97.2%	0.003%
3/4/2025	Siemens Fonds Invest GmbH	27,722	$0.61M	0.0%	N/A	0.002%
2/27/2025	Jefferies Financial Group Inc.	15,048	$0.33M	0.0%	N/A	0.001%
2/26/2025	Capital A Wealth Management LLC	27,033	$0.60M	1.0%	N/A	0.002%
2/25/2025	B. Riley Wealth Advisors Inc.	9,689	$0.21M	0.0%	N/A	0.001%
2/25/2025	Armis Advisers LLC	10,241	$0.23M	0.0%	N/A	0.001%
2/20/2025	Mackenzie Financial Corp	29,889	$0.66M	0.0%	+4.1%	0.003%
2/20/2025	Forum Financial Management LP	18,118	$0.40M	0.0%	+74.7%	0.002%
2/18/2025	Vise Technologies Inc.	13,287	$0.29M	0.0%	N/A	0.001%
2/18/2025	Focus Partners Advisor Solutions LLC	12,574	$0.28M	0.0%	N/A	0.001%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	3,341,063	$73.64M	0.0%	-1.1%	0.295%
2/17/2025	Worldquant Millennium Advisors LLC	224,974	$4.96M	0.0%	N/A	0.020%
2/17/2025	Woodline Partners LP	1,044,610	$23.02M	0.2%	-0.3%	0.092%
2/17/2025	Vident Advisory LLC	43,160	$0.95M	0.0%	-5.1%	0.004%
2/17/2025	Soleus Capital Management L.P.	2,093,000	$46.13M	2.9%	N/A	0.185%
2/17/2025	Two Sigma Advisers LP	1,630,600	$35.94M	0.1%	+57.6%	0.144%
2/17/2025	Two Sigma Investments LP	686,455	$15.13M	0.0%	-4.0%	0.061%
2/17/2025	Tema Etfs LLC	25,662	$0.57M	0.2%	N/A	0.002%
2/17/2025	Safeguard Investment Advisory Group LLC	9,511	$0.21M	0.1%	N/A	0.001%
2/17/2025	Snowden Capital Advisors LLC	32,563	$0.72M	0.0%	-11.8%	0.003%
2/17/2025	Siemens Fonds Invest GmbH	27,722	$0.61M	0.0%	N/A	0.002%
2/17/2025	Sphera Funds Management LTD.	1,569,181	$34.59M	6.2%	-26.3%	0.139%
2/17/2025	Royal Bank of Canada	1,177,603	$25.95M	0.0%	+17.2%	0.104%
2/17/2025	Raiffeisen Bank International AG	8,168	$0.18M	0.0%	N/A	0.001%
2/17/2025	Quantinno Capital Management LP	43,097	$0.95M	0.0%	+19.2%	0.004%
2/17/2025	Parkman Healthcare Partners LLC	196,805	$4.34M	0.6%	-31.0%	0.017%
2/17/2025	Parsifal Capital Management LP	4,372,001	$96.36M	8.0%	-29.9%	0.386%
2/17/2025	Man Group plc	43,302	$0.95M	0.0%	+191.7%	0.004%
2/17/2025	Nissay Asset Management Corp Japan ADV	139,049	$3.17M	0.0%	+1.1%	0.012%
2/17/2025	NWI Management LP	720,000	$15.87M	0.7%	N/A	0.064%
2/17/2025	Noked Israel Ltd	3,285,359	$72.41M	14.3%	+14.6%	0.290%
2/17/2025	Nuveen Asset Management LLC	2,857,007	$62.97M	0.0%	+6.8%	0.252%
2/17/2025	OMERS ADMINISTRATION Corp	21,947	$0.48M	0.0%	-23.5%	0.002%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	138,025	$3.04M	0.2%	+74.4%	0.012%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	10,048	$0.22M	0.0%	+122.2%	0.001%
2/17/2025	Lazard Asset Management LLC	103,230	$2.28M	0.0%	-56.5%	0.009%
2/17/2025	LMR Partners LLP	64,817	$1.43M	0.0%	N/A	0.006%
2/17/2025	Lighthouse Investment Partners LLC	80,000	$1.76M	0.1%	-63.6%	0.007%
2/17/2025	Integral Health Asset Management LLC	500,000	$11.02M	0.9%	N/A	0.044%
2/17/2025	Iron Triangle Partners LP	2,200,036	$48.49M	5.3%	+13.2%	0.194%
2/17/2025	Janus Henderson Group PLC	6,737,625	$148.50M	0.1%	+40.6%	0.595%
2/17/2025	Jefferies Financial Group Inc.	15,048	$0.33M	0.0%	N/A	0.001%
2/17/2025	Graham Capital Management L.P.	76,232	$1.68M	0.0%	+148.4%	0.007%
2/17/2025	Focus Partners Wealth	38,335	$0.85M	0.0%	+8.7%	0.003%
2/17/2025	Ethic Inc.	55,323	$1.22M	0.0%	+45.4%	0.005%
2/17/2025	First Manhattan CO. LLC.	61,675	$1.36M	0.0%	+200.9%	0.005%
2/17/2025	FORA Capital LLC	106,078	$2.34M	0.3%	N/A	0.009%
2/17/2025	Fred Alger Management LLC	139,793	$3.08M	0.0%	-1.8%	0.012%
2/17/2025	Deutsche Bank AG	2,214,543	$48.81M	0.0%	-55.0%	0.195%
2/17/2025	DME Capital Management LP	468,550	$10.33M	0.5%	+44.2%	0.041%
2/17/2025	DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main	118,394	$2.61M	0.0%	+2.3%	0.010%
2/17/2025	Driehaus Capital Management LLC	2,986,111	$65.81M	0.5%	-17.3%	0.264%
2/17/2025	Duquesne Family Office LLC	8,997,400	$198.30M	5.3%	+530.1%	0.794%
2/17/2025	EP Wealth Advisors LLC	23,952	$0.53M	0.0%	-4.7%	0.002%
2/17/2025	Cresset Asset Management LLC	27,351	$0.60M	0.0%	-10.7%	0.002%
2/17/2025	Crestline Management LP	55,371	$1.22M	0.0%	N/A	0.005%
2/17/2025	Cutter Capital Management LP	584,883	$12.89M	5.3%	N/A	0.052%
2/17/2025	CastleKnight Management LP	167,400	$3.69M	0.1%	-23.5%	0.015%
2/17/2025	Cetera Investment Advisers	53,105	$1.17M	0.0%	-1.7%	0.005%
2/17/2025	Bridger Management LLC	695,000	$15.32M	8.2%	-29.2%	0.061%
2/17/2025	Captrust Financial Advisors	8,279	$0.18M	0.0%	-47.6%	0.001%
2/17/2025	Bellevue Group AG	60,598	$1.34M	0.0%	-14.4%	0.005%
2/17/2025	Beverly Hills Private Wealth LLC	9,657	$0.21M	0.0%	N/A	0.001%
2/17/2025	Bank of America Corp DE	4,013,436	$88.46M	0.0%	-32.5%	0.354%
2/17/2025	BNP Paribas	12,655	$0.28M	0.0%	+59.8%	0.001%
2/17/2025	BNP Paribas Financial Markets	1,337,470	$29.48M	0.0%	+14.4%	0.118%
2/17/2025	Ameriprise Financial Inc.	147,649	$3.25M	0.0%	+3.9%	0.013%
2/17/2025	Alyeska Investment Group L.P.	3,641,392	$80.26M	0.3%	+0.5%	0.321%
2/17/2025	Ardsley Advisory Partners LP	300,000	$6.61M	1.0%	-15.0%	0.026%
2/14/2025	Maple Rock Capital Partners Inc.	4,208,741	$92.76M	2.8%	-7.7%	0.371%
2/14/2025	Mercer Global Advisors Inc. ADV	84,480	$1.86M	0.0%	-8.4%	0.007%
2/14/2025	Ion Asset Management Ltd.	36,650,000	$807.77M	47.0%	+1.1%	3.235%
2/14/2025	AdvisorShares Investments LLC	28,696	$0.63M	0.1%	-12.8%	0.003%
2/14/2025	Northern Trust Corp	5,206,360	$114.75M	0.0%	+69.0%	0.460%
2/14/2025	The Manufacturers Life Insurance Company	513,328	$11.31M	0.0%	+18.7%	0.045%
2/14/2025	Marshall & Sterling Wealth Advisors Inc.	2,000	$44K	0.0%	N/A	0.000%
2/14/2025	Public Employees Retirement Association of Colorado	219,826	$4.85M	0.0%	-8.8%	0.019%
2/14/2025	Tri Locum Partners LP	2,423,116	$53.41M	11.1%	-12.1%	0.214%
2/14/2025	Aquatic Capital Management LLC	40,824	$0.90M	0.0%	-83.9%	0.004%
2/14/2025	Capital Analysts LLC	4,616	$0.10M	0.0%	N/A	0.000%
2/14/2025	Lord Abbett & CO. LLC	2,404,895	$53M	0.2%	+66.5%	0.212%
2/14/2025	Voya Investment Management LLC	212,523	$4.68M	0.0%	-21.2%	0.019%
2/14/2025	Adage Capital Partners GP L.L.C.	1,200,000	$26.45M	0.0%	-66.9%	0.106%
2/14/2025	RBF Capital LLC	50,000	$1.10M	0.1%	-44.4%	0.004%
2/14/2025	MGO One Seven LLC	48,813	$1.08M	0.0%	+216.2%	0.004%
2/14/2025	Price T Rowe Associates Inc. MD	2,049,388	$45.17M	0.0%	+148.3%	0.181%
2/14/2025	Dark Forest Capital Management LP	20,000	$0.44M	0.1%	N/A	0.002%
2/14/2025	BlackBarn Capital Partners LP	1,050,000	$23.14M	1.3%	+107.1%	0.093%
2/14/2025	Diadema Partners LP	300,000	$6.68M	2.8%	N/A	0.026%
2/14/2025	Slate Path Capital LP	8,491,033	$187.14M	3.4%	-37.9%	0.749%
2/14/2025	Eversept Partners LP	2,242,125	$49.42M	4.4%	-30.7%	0.198%
2/14/2025	Continental Advisors LLC	341,118	$7.52M	3.5%	-5.7%	0.030%
2/14/2025	Hsbc Holdings PLC	561,289	$12.37M	0.0%	+5.7%	0.050%
2/14/2025	Stifel Financial Corp	88,478	$1.95M	0.0%	+33.3%	0.008%
2/14/2025	TD Waterhouse Canada Inc.	15,599	$0.34M	0.0%	-24.6%	0.001%
2/14/2025	Teachers Retirement System of The State of Kentucky	1,710,000	$37.69M	0.3%	N/A	0.151%
2/14/2025	MetLife Investment Management LLC	133,425	$2.94M	0.0%	+40.4%	0.012%
2/14/2025	BI Asset Management Fondsmaeglerselskab A S	272,634	$6.01M	0.1%	N/A	0.024%
2/14/2025	Beck Mack & Oliver LLC	1,197,490	$26.39M	0.5%	-2.9%	0.106%

Data available starting January 2016

See Full Table

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

Today's Range

Now: $16.38

$16.17

$16.50

50 Day Range

MA: $18.28

$14.69

$22.00

52 Week Range

Now: $16.38

$12.51

$22.80

Volume

6,488,903 shs

Average Volume

12,964,806 shs

Market Capitalization

$18.57 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82

Who are the company insiders with the largest holdings of Teva Pharmaceutical Industries?: Teva Pharmaceutical Industries' top insider investors include:
Roberto Mignone (Director)
Mark Sabag (EVP)
Eliyahu Sharon Kalif (CFO)
Richard D Francis (CEO)
Eric A Hughes (Insider)
Christine Fox (EVP)
Amir Weiss (CAO)
Eric Drape (VP)
Vikki L Conway (Insider)
Eric A Hughes (Insider)
Vikki L Conway (Insider)
Learn More about top insider investors at Teva Pharmaceutical Industries.
Who are the major institutional investors of Teva Pharmaceutical Industries?: Teva Pharmaceutical Industries' top institutional investors include:
FMR LLC — 7.24%
Clal Insurance Enterprises Holdings Ltd — 3.44%
Ion Asset Management Ltd. — 3.24%
Menora Mivtachim Holdings LTD. — 2.51%
Lingotto Investment Management LLP — 2.40%
Migdal Insurance & Financial Holdings Ltd. — 2.30%
Learn More about top institutional investors of Teva Pharmaceutical Industries stock.
Which institutional investors are selling Teva Pharmaceutical Industries stock?: During the previous quarter, TEVA stock was sold by these institutional investors:
Arrowstreet Capital Limited Partnership
Slate Path Capital LP
Deutsche Bank AG
Adage Capital Partners GP L.L.C.
Bank of America Corp DE
Parsifal Capital Management LP
Legal & General Group Plc
Sound Shore Management Inc. CT
In the previous year, company insiders that have sold Teva Pharmaceutical Industries company stock include:
Roberto Mignone (Director)
Mark Sabag (EVP)
Eliyahu Sharon Kalif (CFO)
Richard D Francis (CEO)
Eric A Hughes (Insider)
Learn More investors selling Teva Pharmaceutical Industries stock.
Which institutional investors are buying Teva Pharmaceutical Industries stock?: Within the last quarter, TEVA stock was acquired by institutional investors including:
FMR LLC
Duquesne Family Office LLC
Clal Insurance Enterprises Holdings Ltd
Todd Asset Management LLC
Marshall Wace LLP
Northern Trust Corp
Soleus Capital Management L.P.
Janus Henderson Group PLC